Evidence map›Paper›PMID 19125816›Full record

ReviewEnvironmental microbiology2009

Insights on Escherichia coli biofilm formation and inhibition from whole-transcriptome profiling.

Thomas K Wood

Open access · bronzeAbstract readReview
In one paragraph

Review in Environmental microbiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 203 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Alkanna tinctoria extract-mediated biomass synthesis of Ag-ZnO nanoparticles: characterization, antimicrobial and antibiofilm activities.International microbiology : the official journal of the Spanish Society for Microbiology · 2025
    Article
  7. Effects of UVC Treatment on Biofilms ofFoods (Basel, Switzerland) · 2025
    Article
  8. Review
  9. Article
  10. Article
  11. Comparative evaluation of biofilm-forming capacity in uropathogenic and commensalFrontiers in cellular and infection microbiology · 2025
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Thomas K WoodArtie McFerrin Department of Chemical Engineering, Texas A & M University, College Station, TX 77843-3122, USA. Thomas.Wood@chemail.tamu.edu
Texas A&M University · US

Funding

Plant Biofilm Inhibitors to Discover Biofilm GenesR01EB003872 · NIBIB · TEXAS ENGINEERING EXPERIMENT STATION · PI WOOD, THOMAS K · 2005 to 2008
$1.2M
NIBIB NIH HHS R01 EB003872NIBIB NIH HHS R01 EB00387205
6 · The paper itself

Abstract

Biofilms transform independent cells into specialized cell communities. Here are presented some insights into biofilm formation ascertained with the best-characterized strain, Escherichia coli. Investigations of biofilm formation and inhibition with this strain using whole-transcriptome profiling coupled to phenotypic assays, in vivo DNA binding studies and isogenic mutants have led to discoveries related to the role of stress, to the role of intra- and interspecies cell signalling, to the impact of the environment on cell signalling, to biofilm inhibition by manipulating cell signalling, to the role of toxin/antitoxin genes in biofilm formation, and to the role of small RNAs on biofilm formation and dispersal. Hence, E. coli is an excellent resource for determining paradigms in biofilm formation and biofilm inhibition.

Indexed as

Gene Expression ProfilingGene Expression Regulation, BacterialBiofilmsEscherichia coli

Identifiers

PMID19125816
PMCPMC2621073
OpenAlexW2127371670

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.